Oxidized Low-Density Lipoprotein (Ox-LDL)-Triggered Double-Lock Probe for Spatiotemporal Lipoprotein Oxidation and Atherosclerotic Plaque Imaging. 2023

Xu Zhi, and Yufen Sun, and Fangjian Cai, and Sisi Wang, and Hu Gao, and Fan Wu, and Lei Zhang, and Zhen Shen
State Key Laboratory of Coordination Chemistry, Collaborative Innovation Center of Advanced Microstructures, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210023, China.

Low-density lipoprotein (LDL), especially oxidative modified LDL (Ox-LDL), is the key risk factor for plaque accumulation and the development of cardiovascular disease. Herein, a highly specific Ox-LDL-triggered fluorogenic-colorimetric probe Pro-P1 is developed for visualizing the oxidation and aggregation progress of lipoproteins and plaque. A series of green fluorescent protein chromophores with modified donor-acceptor structures, containing carbazole as an electron donor and various substituents including pyridine-vinyl (P1), phenol-vinyl (P2), N, N-dimethylaniline-vinyl (P3), and thiophene-vinyl (P4), have been synthesized and evaluated. Emission spectroscopy and theoretical calculations of P1-P4 indicate that P1 shows enhanced green fluorescence (λem = 560 nm) by inhibiting its twisted intramolecular charge transfer in the presence of Ox-LDL. This feature allows the selection of P1 as a sensitive probe to directly visualize ferroptosis and Cu2+ -mediated LDL oxidative aggregation via in situ formation of fluorophore-bound Ox-LDL in living cells. The red-emissive probe Pro-P1 (λem = 660 nm) is prepared via borate protection of P1, which can be cleaved into P1 under high expression of HOCl and Ox-LDL condition at the lesion site, resulting in enhanced green emission. The plaque area and size with clear boundaries can be delineated by colorimetric fluorescence imaging and fluorescence lifetime imaging with precise differentiation.

UI MeSH Term Description Entries
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D058226 Plaque, Atherosclerotic Lesions formed within the walls of ARTERIES associated with deposits of fat and other substances that accumulate in the lining of the artery wall. Atheromatous Plaque,Atheroma,Atheromatous Plaques,Atherosclerotic Plaque,Atherosclerotic Plaques,Fatty Streak, Arterial,Fibroatheroma,Fibroatheromatous Plaques,Arterial Fatty Streak,Arterial Fatty Streaks,Atheromas,Fibroatheromas,Fibroatheromatous Plaque,Plaque, Atheromatous,Plaque, Fibroatheromatous,Streak, Arterial Fatty

Related Publications

Xu Zhi, and Yufen Sun, and Fangjian Cai, and Sisi Wang, and Hu Gao, and Fan Wu, and Lei Zhang, and Zhen Shen
February 2004, Clinical chemistry and laboratory medicine,
Xu Zhi, and Yufen Sun, and Fangjian Cai, and Sisi Wang, and Hu Gao, and Fan Wu, and Lei Zhang, and Zhen Shen
September 2016, Clinical laboratory,
Xu Zhi, and Yufen Sun, and Fangjian Cai, and Sisi Wang, and Hu Gao, and Fan Wu, and Lei Zhang, and Zhen Shen
October 2009, Journal of biomechanics,
Xu Zhi, and Yufen Sun, and Fangjian Cai, and Sisi Wang, and Hu Gao, and Fan Wu, and Lei Zhang, and Zhen Shen
May 1997, Clinical and experimental immunology,
Xu Zhi, and Yufen Sun, and Fangjian Cai, and Sisi Wang, and Hu Gao, and Fan Wu, and Lei Zhang, and Zhen Shen
November 2002, The American journal of cardiology,
Xu Zhi, and Yufen Sun, and Fangjian Cai, and Sisi Wang, and Hu Gao, and Fan Wu, and Lei Zhang, and Zhen Shen
July 2002, Clinical nephrology,
Xu Zhi, and Yufen Sun, and Fangjian Cai, and Sisi Wang, and Hu Gao, and Fan Wu, and Lei Zhang, and Zhen Shen
January 2013, Nuclear medicine and biology,
Xu Zhi, and Yufen Sun, and Fangjian Cai, and Sisi Wang, and Hu Gao, and Fan Wu, and Lei Zhang, and Zhen Shen
September 1997, Journal of lipid research,
Xu Zhi, and Yufen Sun, and Fangjian Cai, and Sisi Wang, and Hu Gao, and Fan Wu, and Lei Zhang, and Zhen Shen
January 2006, Physiological research,
Xu Zhi, and Yufen Sun, and Fangjian Cai, and Sisi Wang, and Hu Gao, and Fan Wu, and Lei Zhang, and Zhen Shen
May 2013, International journal of radiation biology,
Copied contents to your clipboard!